Physiomics plc (PYC) ORD GBP0.004
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Physiomics announces new modelling and data sciences manager
4 November 2024 12:11
(Sharecast News) - Physiomics announced the appointment of Mark Davies as its head of quantitative pharmacology and data science on Monday.
-
Physiomics secures new contract from existing pharma client
17 September 2024 13:38
(Sharecast News) - Physiomics, a specialist in mathematical modelling and data science for drug development and personalised medicine, announced on Tuesday that it has secured a new contract worth £65,000...
-
Physiomics secures new contract from existing pharma client
17 September 2024 13:38
(Sharecast News) - Physiomics, a specialist in mathematical modelling and data science for drug development and personalised medicine, announced on Tuesday that it has secured a new contract worth £65,000...
-
Physiomics re-engages with DoseMe for personalised dosing software
14 June 2024 09:51
(Sharecast News) - Physiomics, a mathematical modelling and data science specialist focussed on therapeutics and personalised medicine, has re-engaged with DoseMe to implement its personalised dosing...
-
Physiomics wins new contract with existing client
13 June 2024 09:56
(Sharecast News) - Data sciences business Physiomics said on Thursday that it has been awarded a new contract by an existing, large client.
-
Physiomics lowers forecasts amid contract delays
3 May 2024 11:21
(Sharecast News) - Therapeutics and medicine-focussed mathematical modelling and data science company Physiomics said in an update on Friday that, despite a robust pipeline of potential new business, it had...
-
Physiomics secures 'substantial new contract' with existing pharma client
18 March 2024 09:43
(Sharecast News) - Mathematical modelling and data science company Physiomics has been awarded "a substantial new contract" by an existing large pharmaceutical client.
-
Physiomics revenue rises, losses narrow in first half
7 March 2024 12:50
(Sharecast News) - Physiomics reported revenue of £0.37m in its interim results on Thursday, up from the £0.34m it recorded a year earlier.
-
Physiomics secures contract with University of Sheffield
19 February 2024 10:16
(Sharecast News) - Data science firm Physiomics has been chosen by the University of Sheffield to support a grant-funded project focused on an insect model of cancer treatment.
-
Physiomics awarded further contract by Numab Therapeutics
5 February 2024 10:01
(Sharecast News) - Data science company Physiomics said on Monday that it had been awarded a further contract by an existing client.
-
Physiomics receives Innovate UK funding grant
10 November 2023 08:14
(Sharecast News) - Computational biology firm Physiomics said on Friday that it had been awarded a grant by Innovate UK and the Office for Life Sciences as part of the UK Government's Advancing...
-
Physiomics inks contract extension with Numab Therapeutics
8 August 2023 15:49
(Sharecast News) - Mathematical modelling company Physiomics, which specialises in the development of oncology drugs and personalised medicine, confirmed a renewed contract with Numab Therapeutics on Tuesday.
Company announcements Announcements
-
Result of AGM
19 November 2024 16:50
Physiomics
-
Director Dealing
8 November 2024 07:00
Physiomics
-
Senior Management Announcement
4 November 2024 07:00
Physiomics
-
Notice of AGM
17 October 2024 07:00
Physiomics
-
Contract Award
17 October 2024 07:00
Physiomics
-
Annual Financial Report
27 September 2024 07:00
Physiomics
-
Notice of Results and Investor Presentation
19 September 2024 07:00
Physiomics
-
Contract Award
17 September 2024 07:00
Physiomics
-
Result of WRAP Retail Offer
5 July 2024 07:00
Physiomics
-
WRAP Retail Offer for up to £25,000
3 July 2024 07:00
Physiomics
-
Completion of Placing & WRAP Retail Offer Launch
3 July 2024 07:00
Physiomics
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.